Profund Advisors’s Regenxbio RGNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $106K | Buy |
+12,921
| New | +$106K | ﹤0.01% | 960 |
|
|
2025
Q1 | – | Sell |
-18,256
| Closed | -$141K | – | 1086 |
|
|
2024
Q4 | $141K | Buy |
18,256
+1,398
| +8% | +$10.8K | 0.01% | 1051 |
|
|
2024
Q3 | $177K | Sell |
16,858
-3,749
| -18% | -$39.3K | 0.01% | 1069 |
|
|
2024
Q2 | $241K | Sell |
20,607
-8,893
| -30% | -$104K | 0.01% | 858 |
|
|
2024
Q1 | $622K | Buy |
29,500
+7,850
| +36% | +$165K | 0.02% | 502 |
|
|
2023
Q4 | $389K | Sell |
21,650
-2,277
| -10% | -$40.9K | 0.02% | 647 |
|
|
2023
Q3 | $394K | Sell |
23,927
-6,244
| -21% | -$103K | 0.02% | 537 |
|
|
2023
Q2 | $603K | Buy |
30,171
+4,452
| +17% | +$89K | 0.03% | 453 |
|
|
2023
Q1 | $486K | Buy |
+25,719
| New | +$486K | 0.03% | 512 |
|
|
2018
Q4 | – | Sell |
-5,408
| Closed | -$408K | – | 1357 |
|
|
2018
Q3 | $408K | Sell |
5,408
-478
| -8% | -$36.1K | 0.02% | 962 |
|
|
2018
Q2 | $422K | Buy |
+5,886
| New | +$422K | 0.02% | 909 |
|